Fine, Amena Smith
Nemeth, Christina L.
Kaufman, Miriam L.
Fatemi, Ali
Funding for this research was provided by:
National Institutes of Health (R01 NS097511-01, 5T32HD007414-25)
Intellectual and Developmental Disabilities Research Center (US4HD079123)
Article History
Received: 18 February 2019
Accepted: 11 November 2019
First Online: 16 December 2019
Ethics approval and consent to participate
: Not applicable
: Not applicable
: Regarding interests to declare, Dr. Fatemi is a paid drug safety monitoring board member for Bluebird Bio, Stealth Biotherapeutics, and paid consultant to Calico Labs. All other authors declare that they have no competing interests.